135P A multicenter retrospective observation study about overall survival benefit of eribulin mesylate in comparison with taxane regimens for metastatic cancer patients
Titel:
135P A multicenter retrospective observation study about overall survival benefit of eribulin mesylate in comparison with taxane regimens for metastatic cancer patients
Auteur:
Kikuchi, Y. Uchida, Y. Kanauchi, H. Niwa, T. Nishioka, K. Tada, K. Hashimoto, M. Yasuda, H. Kawabata, H. Seto, Y. Ogawa, T.